Initial Evaluation of Anti-1-amino-F-18 Flurocyclobutane-1carboxylic Acid (Anti-18F-FACBC) in the Assessment of Head and Neck Cancer: A Pilot Study.
Withdrawn prior to enrolment
Phase of Trial: Phase 0
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Head and neck cancer
- Focus Diagnostic use
- 01 Feb 2018 Planned End Date changed from 31 Mar 2018 to 1 Feb 2018.
- 01 Feb 2018 Planned primary completion date changed from 31 Mar 2018 to 1 Feb 2018.
- 01 Feb 2018 Status changed from suspended to withdrawn prior to enrolment.